Inovio Pharmaceuticals Inc (NAS:INO)
$ 12.115 -0.675 (-5.28%) Market Cap: 312.22 Mil Enterprise Value: 239.21 Mil PE Ratio: 0 PB Ratio: 2.34 GF Score: 49/100

Q1 2021 Inovio Pharmaceuticals Inc Earnings Call Transcript

May 10, 2021 / 08:30PM GMT
Release Date Price: $80.04 (-2.63%)
Operator

Good day, and welcome to the Inovio Pharmaceuticals First Quarter 2021 Financial Results Conference Call. (Operator Instructions) Please note, this event is being recorded.

I'd now like to turn the conference over to Ben Matone, Senior Director of Investor Relations. Please go ahead.

Ben Matone
Inovio Pharmaceuticals, Inc. - Director of IR

Thank you, operator. Thank you for joining the Inovio First Quarter 2021 Earnings Conference call. Joining me on today's call are Dr. Joseph Kim, President and CEO; Mr. Peter Kies, CFO; Dr. Jackie Shea, Chief Operating Officer; Dr. Laurent Humeau, Chief Scientific Officer; Dr. Anza Mammen, Senior Vice President of Clinical Development; and Dr. Kate Broderick, Senior Vice President of Research and Development.

For today's call, we will review our corporate and financial information for the first quarter ended March 31, 2021. In addition, we will discuss this morning's press release regarding the Phase II data from our INNOVATE trial for COVID-19 as well as provide an update on the company's path forward for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot